Petitclerc Claude
Département de Biochimie, Centre Hospitalier de I'Université de Montréal, Hôpital Notre-Dame, Montréal, Canada.
Clin Chem Lab Med. 2004;42(7):698-701. doi: 10.1515/CCLM.2004.119.
The concept of reference values is widely accepted, but their application has been quite lax over the years. This is due primarily to the difficulty of properly selecting and documenting samples from a reference population. In the absence of a clear description of reference individuals, reference values lose their meaning, are ambiguous at best, and are often confused with decision limits. The clinical medicine perspective of reference values is to rule out diseases and to define health, while that of preventive medicine is to appreciate the state of health. Defining reference limits and normality in this context is a great challenge. Advances in the fields of genomics and proteomics and the rapid pace of technological advances help highlight the biological diversity among individuals. However, there is a great need for reference values that are representative of healthy humans and presented in a manner that they can be utilized by all laboratories. In addition, as secure information technology becomes available, the goal of using an individual as their own reference during a lifetime is now possible, provided that consistency of databases is ensured.
参考值的概念已被广泛接受,但多年来其应用一直相当宽松。这主要是由于从参考人群中正确选择和记录样本存在困难。在缺乏对参考个体的清晰描述的情况下,参考值就失去了意义,充其量只是模糊不清,而且常常与决策界限相混淆。临床医学对参考值的看法是排除疾病并定义健康,而预防医学的看法则是了解健康状况。在这种情况下定义参考界限和正常状态是一项巨大的挑战。基因组学和蛋白质组学领域的进展以及技术进步的快速步伐有助于凸显个体之间的生物多样性。然而,非常需要能够代表健康人群且以所有实验室都能使用的方式呈现的参考值。此外,随着安全信息技术的出现,只要确保数据库的一致性,以个体自身作为一生的参考这一目标现在是可行的。